{
  "@context": {
    "@vocab": "https://openminds.ebrains.eu/vocab/"
  },
  "@id": "https://openminds.ebrains.eu/instances/molecularEntity/6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione",
  "@type": "https://openminds.ebrains.eu/controlledTerms/MolecularEntity",
  "definition": "DNQX (6,7-dinitroquinoxaline-2,3-dione) is a competitive antagonist at AMPA and kainate receptors, two ionotropic glutamate receptor (iGluR) subfamilies. [adapted from wikipedia (https://en.wikipedia.org/wiki/DNQX)]",
  "description": "DNQX (6,7-dinitroquinoxaline-2,3-dione) is used in a variety of molecular biology subfields, notably neurophysiology, to assist researchers in determining the properties of various types of ion channels and their potential applications in medicine. [adapted from wikipedia (https://en.wikipedia.org/wiki/DNQX)]",
  "interlexIdentifier": "http://uri.interlex.org/base/ilx_0103368",
  "knowledgeSpaceLink": null,
  "name": "6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione",
  "preferredOntologyIdentifier": "https://pubchem.ncbi.nlm.nih.gov/compound/3899541",
  "synonym": [
    "DNQX",
    "6,7-dinitroquinoxaline-2,3-dione",
    "6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione"
  ]
}
